tiletamine hydrochloride has been researched along with Peritoneal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Fujiyoshi, M; Haga, S; Kamiyama, T; Mino, K; Nakanishi, K; Niwa, H; Ohmiya, Y; Ozaki, M; Sato, M; Taketomi, A; Todo, S; Umezawa, K; Yokoo, H | 1 |
| Haga, S; Kamiyama, T; Kataoka, A; Kina, M; Mino, K; Nakanishi, K; Ochiya, T; Ozaki, M; Sato, M; Takahashi, M; Takahashi, N; Todo, S; Umezawa, K; Yanagihara, K | 1 |
2 other study(ies) available for tiletamine hydrochloride and Peritoneal Neoplasms
| Article | Year |
|---|---|
Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
Topics: Animals; Anoikis; Apoptosis Regulatory Proteins; Benzamides; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Gene Expression; Genes, Reporter; Humans; Mice; Molecular Imaging; NF-kappa B; Pancreatic Neoplasms; Peritoneal Neoplasms; Protein Binding; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Adhesion; Cell Line, Tumor; Cell Separation; Cyclohexanones; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Peritoneal Neoplasms; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2011 |